Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin for Cerebral Perfusion Augmentation
NCT04545892Phase 1Completed
- Start
- Dec 2019
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of capsaicin in stroke (5 arms). Primary endpoints: Mean velocity at 20 minutes and Pulsatility Index at 20 minutes. Started Dec 2019; status: completed.
02
Drugs
capsaicin
03
Conditions
stroke
Beyond the preview
Go deeper on NCT04545892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04545892.